Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03468855 · ClinicalTrials.gov registry record · Phase 2

A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo

A Phase 2 study of Vitiligo, sponsored by Aclaris Therapeutics.

Completed
Registry status
Phase 2
Development phase
34
Enrollment target
5
Study locations

NCT03468855 is a Phase 2 study of Vitiligo that has completed, run by Aclaris Therapeutics. The registered enrollment target is 34 participants, below the 1,122-participant average among 15 other Vitiligo trials with a reported enrollment target (97% lower). The trial reports 5 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03468855, a Phase 2 study of Vitiligo, has completed, sponsored by Aclaris Therapeutics.

COMPLETED
Registry status
Phase 2
Development phase
34 participants
Enrollment target
5
Study locations

Study Summary

The main objective of this study is to assess the safety, tolerability and efficacy of ATI-50002 Topical Solution, 0.46% in subjects with non-segmental facial vitiligo.

Conditions Studied

Vitiligo

Interventions

  • DRUG ATI-50002 topical solution

Study Locations (5)

California

  • Aclaris Investigator Site - Encinitas
  • Aclaris Investigator Site - Los Angeles

Massachusetts

  • Aclaris Investigator Site - Worcester

Texas

  • Aclaris Investigator Site - Dallas

Virginia

  • Aclaris Investigator Site - Lynchburg

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2018-03-19
Est. Completion 2019-10-16
Phase Phase 2

Sponsor

Aclaris Therapeutics

33 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT03468855

The ClinicalTrials.gov registry entry for NCT03468855 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,122-participant average among 15 other Vitiligo trials with a reported enrollment target (97% lower). The listed sponsor is Aclaris Therapeutics, which has 33 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Vitiligo appearing as the primary indexed condition, and to 1 intervention - of which ATI-50002 topical solution is the first listed.

NCT03468855 reports 5 study locations spanning 4 distinct geographic areas - top geographies include California, Massachusetts, Texas.

Frequently Asked Questions

What is clinical trial NCT03468855 about?

NCT03468855 is a clinical study titled "A Study of ATI-50002 Topical Solution for the Treatment of Vitiligo". The main objective of this study is to assess the safety, tolerability and efficacy of ATI-50002 Topical Solution, 0.46% in subjects with non-segmental facial vitiligo.

What is the current status of trial NCT03468855?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 34 participants. The study started on 2018-03-19. Estimated completion is 2019-10-16.

What conditions does trial NCT03468855 study?

This clinical trial studies the following conditions: Vitiligo.

What interventions are being tested in trial NCT03468855?

The interventions under investigation include: ATI-50002 topical solution (DRUG).

Who is sponsoring clinical trial NCT03468855?

This trial is sponsored by Aclaris Therapeutics, which has 33 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03468855 being conducted?

This trial has 5 study locations across California, Massachusetts, Texas, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Vitiligo

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Vitiligo

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.